Sinapic Acid Attenuate Liver Injury by Modulating Antioxidant Activity and Inflammatory Cytokines in Thioacetamide-Induced Liver Cirrhosis in Rats

• Published in: Biomedicines Vol. 11; no. 5; p. 1447
• Main Authors: Jabbar, Ahmed A J, Alamri, Zaenah Zuhair, Abdulla, Mahmood Ameen, AlRashdi, Ahmed S, Najmaldin, Soran Kayfi, Zainel, Mustafa AbdulMonam
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 15-05-2023; MDPI
• Subjects: Acids; Actin; Acute toxicity; Albumin; Alternative medicine; Antioxidants; Bilirubin; Cell proliferation; Cereals; Cirrhosis; Cytokines; Down-regulation; Drug dosages; Enzymes; Fibrosis; Hepatitis; Hepatocytes; Hepatotoxicity; histology; Hsp70 protein; Hypertension; Immunohistochemistry; Inflammation; Interleukin 10; Interleukin 6; Laboratory animals; Lipid peroxidation; Lipids; Liver; Liver cirrhosis; Liver diseases; Lymphocytes; Males; Silymarin; Sinapic acid; Smooth muscle; TAA; Thioacetamide; Tumor necrosis factor-TNF; Tumor necrosis factor-α; United States > US; immunohistochemistry; histology; TAA; sinapic acid; liver cirrhosis
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines11051447

Sinapic acid (SA) is a natural pharmacological active compound found in berries, nuts, and cereals. The current study aimed to investigate the protective effects of SA against thioacetamide (TAA) fibrosis in rats by histopathological and immunohistochemical assays. The albino rats (30) were randomly divided into five groups (G). G1 was injected with distilled water 3 times/week and fed orally daily with 10% Tween 20 for two months. G2-5 were injected with 200 mg/kg TAA three times weekly for two months and fed with 10% Tween 20, 50 mg/kg silymarin, 20, and 40 mg/kg of SA daily for 2 months, respectively. The results showed that rats treated with SA had fewer hepatocyte injuries with lower liver index (serum bilirubin, total protein, albumin, and liver enzymes (ALP, ALT, and AST) and were similar to that of control and silymarin-treated rats. Acute toxicity for 2 and 4 g/kg SA showed to be safe without any toxic signs in treated rats. Macroscopic examination showed that hepatotoxic liver had an irregular, rough surface with micro and macro nodules and histopathology expressed by Hematoxylin and Eosin, and Masson Trichrome revealed severe inflammation and infiltration of focal necrosis, fibrosis, lymphocytes, and proliferation bile duct. In contrast, rats fed with SA had significantly lower TAA toxicity in gross and histology and liver tissues as presented by less liver tissue disruption, lesser fibrosis, and minimum in filtered hepatocytes. Immunohistochemistry of rats receiving SA showed significant up-regulation of HSP 70% and down-regulation of alpha-smooth muscle actin (α-SMA) protein expression compared to positive control rats. The homogenized liver tissues showed a notable rise in the antioxidant enzymes (SOD and CAT) actions with significantly lower malondialdehyde (MDA) levels compared to that of the positive control group. Furthermore, the SA-treated rats had significantly lower TNF-a, IL-6, and higher IL-10 levels than the positive control rats. Thus, the findings suggest SA as a hepatoprotective compound due to its inhibitory effects on fibrosis, hepatotoxicity, liver cell proliferation, up-regulation of HSP 70, and downregulation of α-SMA expression, inhibiting lipid peroxidation (MDA), while retaining the liver index and antioxidant enzymes to normal.